Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01LMW
|
|||
Drug Name |
Pyrrolo[2,3-b]pyridine derivative 4
|
|||
Synonyms |
PMID25656651-Compound-24
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
NOVA DECISION [FRAZASYNTH [FR]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H14F3N3O2
|
|||
Canonical SMILES |
COC(=O)C1=CC2=CC(=CN=C2N1)NCC3=CC=CC=C3C(F)(F)F
|
|||
InChI |
1S/C17H14F3N3O2/c1-25-16(24)14-7-11-6-12(9-22-15(11)23-14)21-8-10-4-2-3-5-13(10)17(18,19)20/h2-7,9,21H,8H2,1H3,(H,22,23)
|
|||
InChIKey |
MFAPLYWBOUSVJJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.